These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 25929954

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Risk factors for bronchiectasis in children with cystic fibrosis.
    Sly PD, Gangell CL, Chen L, Ware RS, Ranganathan S, Mott LS, Murray CP, Stick SM, AREST CF Investigators.
    N Engl J Med; 2013 May 23; 368(21):1963-70. PubMed ID: 23692169
    [Abstract] [Full Text] [Related]

  • 3. Matrix metalloproteinases vary with airway microbiota composition and lung function in non-cystic fibrosis bronchiectasis.
    Taylor SL, Rogers GB, Chen AC, Burr LD, McGuckin MA, Serisier DJ.
    Ann Am Thorac Soc; 2015 May 23; 12(5):701-7. PubMed ID: 25679336
    [Abstract] [Full Text] [Related]

  • 4. Induced sputum matrix metalloproteinase-9 correlates with lung function and airway inflammation in children with cystic fibrosis.
    Sagel SD, Kapsner RK, Osberg I.
    Pediatr Pulmonol; 2005 Mar 23; 39(3):224-32. PubMed ID: 15635615
    [Abstract] [Full Text] [Related]

  • 5. Exhaled breath condensate MMP-9 levels in children with bronchiectasis.
    Karakoc GB, Inal A, Yilmaz M, Altintas DU, Kendirli SG.
    Pediatr Pulmonol; 2009 Oct 23; 44(10):1010-6. PubMed ID: 19725099
    [Abstract] [Full Text] [Related]

  • 6. Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema.
    Ohnishi K, Takagi M, Kurokawa Y, Satomi S, Konttinen YT.
    Lab Invest; 1998 Sep 23; 78(9):1077-87. PubMed ID: 9759652
    [Abstract] [Full Text] [Related]

  • 7. Key inflammatory markers in bronchoalveolar lavage predict bronchiectasis progression in young children with CF.
    Horati H, Margaroli C, Chandler JD, Kilgore MB, Manai B, Andrinopoulou ER, Peng L, Guglani L, Tiddens HAMW, Caudri D, Scholte BJ, Tirouvanziam R, Janssens HM.
    J Cyst Fibros; 2024 May 23; 23(3):450-456. PubMed ID: 38246828
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in sera and tissue of patients with Dupuytren's disease.
    Ulrich D, Hrynyschyn K, Pallua N.
    Plast Reconstr Surg; 2003 Oct 23; 112(5):1279-86. PubMed ID: 14504511
    [Abstract] [Full Text] [Related]

  • 14. Sputum matrix metalloproteinase-8 and -9 and tissue inhibitor of metalloproteinase-1 in bronchiectasis: clinical correlates and prognostic implications.
    Guan WJ, Gao YH, Xu G, Lin ZY, Tang Y, Gu YY, Liu GH, Li HM, Chen RC, Zhong NS.
    Respirology; 2015 Oct 23; 20(7):1073-81. PubMed ID: 26122009
    [Abstract] [Full Text] [Related]

  • 15. Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging.
    Baker EA, Bergin FG, Leaper DJ.
    Br J Surg; 2000 Sep 23; 87(9):1215-21. PubMed ID: 10971431
    [Abstract] [Full Text] [Related]

  • 16. Imbalance between matrix metalloproteinases (MMP-9 and MMP-2) and tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in acute respiratory distress syndrome patients.
    Lanchou J, Corbel M, Tanguy M, Germain N, Boichot E, Theret N, Clement B, Lagente V, Malledant Y.
    Crit Care Med; 2003 Feb 23; 31(2):536-42. PubMed ID: 12576963
    [Abstract] [Full Text] [Related]

  • 17. Effect of Pseudomonas aeruginosa on the expressions of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in the airway of bronchiectasis patients.
    Jin Q, Huang FH, Zhou Y, Zhang YQ, Chai XJ.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Aug 23; 34(4):384-9. PubMed ID: 22954123
    [Abstract] [Full Text] [Related]

  • 18. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats.
    Zhang X, Sakamoto T, Hata Y, Kubota T, Hisatomi T, Murata T, Ishibashi T, Inomata H.
    Exp Eye Res; 2002 May 23; 74(5):577-84. PubMed ID: 12076079
    [Abstract] [Full Text] [Related]

  • 19. Altered expression of matrix metalloproteinases and their tissue inhibitors as possible contributors to corneal droplet formation in climatic droplet keratopathy.
    Holopainen JM, Serra HM, Sánchez MC, Sorsa T, Zalentein WN, Barcelona PF, Moilanen JA, Tervahartiala T, Tervo TM, Cafaro TA, Virtanen I, Urrets-Zavalia EA, Bhattacharya SK, Urrets-Zavalia JA.
    Acta Ophthalmol; 2011 Sep 23; 89(6):569-74. PubMed ID: 19900203
    [Abstract] [Full Text] [Related]

  • 20. MMP-9 protein level does not reflect overall MMP activity in the airways of patients with COPD.
    Lowrey GE, Henderson N, Blakey JD, Corne JM, Johnson SR.
    Respir Med; 2008 Jun 23; 102(6):845-51. PubMed ID: 18328682
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.